UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2025 Earnings Call Transcript May 12, 2025
UroGen Pharma Ltd. misses on earnings expectations. Reported EPS is $-0.92 EPS, expectations were $-0.83.
Operator: Hello and welcome to UroGen Pharma First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Vincent...
